Vaccine financing in the United States: An emerging crisis

Archives of Pediatrics and Adolescent Medicine

Volumn 163, Issue 5, 2009, Pages 485-487

  Lee, Grace M ^a   Lieu, Tracy A ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

DRUG COST; EDITORIAL; FUNDING; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH CARE POLICY; MEDICAID; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; REIMBURSEMENT; UNITED STATES; VACCINATION;

CHILD; ECONOMICS; FINANCING, GOVERNMENT; HUMANS; UNITED STATES; VACCINES;

EID: 66149142782     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2009.70     Document Type: Editorial

References (16)

1. Johnson KA, Sardell A, Richards B. Federal immunization policy and funding: a history of responding to crises. Am J Prev Med. 2000;19(3)(suppl):99- 112.
2. The National Vaccine Advisory Committee. The measles epidemic: problems, barriers, and recommendations. JAMA. 1991;266(11):1547-1552.
3. Institute of Medicine Board on Health Care Services. Financing Vaccines in the 21st Century. Assuring Access and Availability. Washington, DC: The National Academic Press; 2004.
4. Zimmerman RK, Mieczkowski TA, Mainzer HM, et al. Effect of the Vaccines for Children program on physician referral of children to public vaccine clinics: a pre-post comparison. Pediatrics. 2001;108(2):297-304.
5. Szilagyi PG, Humiston SG, Pollard Shone L, Kolasa MS, Rodewald LE. Decline in physician referrals to health department clinics for immunizations: the role of vaccine financing. Am J Prev Med. 2000;18(4):318-324.
6. Orenstein WA. The role of measles elimination in development of a national immunization program. Pediatr Infect Dis J. 2006;25(12):1093-1101.
7. Davis MM, Zimmerman JL, Wheeler JR, Freed GL. Childhood vaccine purchase costs in the public sector: past trends, future expectations. Am J Public Health. 2002;92(12):1982-1987.
8. Lee GM, Santoli JM, Hannan C, et al. Gaps in vaccine financing for underinsured children in the United States. JAMA. 2007;298(6):638-643.
9. Dempsey AF, Davis MM. Overcoming barriers to adherence to HPV vaccination recommendations. Am J Manag Care. 2006;12(17)(suppl):S484-S491.
10. Davis MM. Reasons and remedies for underinsurance for child and adolescent vaccines. JAMA. 2007;298(6):680-682.
11. Abramson JS, Almquist JR, Jenkins RR, et al. Prioritisation of routine vaccines: a mistake for the USA. Lancet. 2008;371(9616):881-882.
12. Ortega-Sanchez IR, Lee GM, Jacobs RJ, et al; Working Group on Leading Economic Issues for New Vaccine for Adolescents. Projected cost-effectiveness of new vaccines for adolescents in the United States. Pediatrics. 2008;121(suppl 1):S63-S78.
13. American Academy of Pediatrics. 2007/08 AAP Medicaid Reimbursement Survey. www.aap.org/research/medreimpdf0708/49state-DC.pdf. Published April 2008. Accessed February 13, 2009.
14. Freed GL, Cowan AE, Gregory S, Clark SJ. Variation in provider vaccine purchase prices and payer reimbursement. Pediatrics. 2008;122(6):1325-1331.
15. Pediatric Supersite Web site. http://www.pediatricsupersite.com/view. aspx?rid=36214. Accessed February 13, 2009.
16. Freed GL, Cowan AE, Clark SJ. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics. 2008;122(6):1319-1324.